CognitrexCancerDigest

4baseCare, a precision oncology company in India, launched their product - TARGT Indiegene, India's largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1,500 cancer patients across 28 different cancer types. Most of the patients were presented with stage III/IV disease, and presented with disease progression and had exhausted all the options in the standard of care. Most of the cancer panels currently available in the market are based on data from the Caucasian population, and the same panel is used for testing across all the geographies. For example, the TARGT Indiegene' cancer panel is based on insights generated from tumour tissues of Indian cancer patients resulting in better success rates using precision medicine in the management of cancer. The insights from research have helped build the largest resource of mutational signatures identified in cancer patients in India. Research has provided insights into 1,...

First-of-its-kind initiative provides patients in India with access to remote opinions and consultations, using technology from India-based telemedicine provider iCliniq Physical location in Chennai , India will serve as a telemedicine hub to coordinate with Memorial Sloan Kettering Cancer Center specialists NEW YORK and CHENNAI , India , Aug. 2, 2021 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, has launched MSKCC India to provide cancer patients in India with access to the institution's world-renowned oncologists, research, clinical trials, and education. The effort stems from the institution's core mission of advancing transformative cancer care through education and research worldwide. As part of this first-of-its-kind offering, MSKCC India will provide remote opinions via video or written consultations. A Memorial Sloan Kettering Cancer Center oncologist who specializes in a patient's form of...